Tuesday, January 14, 2020 9:50:00 AM
7:50 AM ET 1/14/20 | Dow Jones
By Michael Dabaie
La Jolla Pharmaceutical Co. (LJPC) shares were up 13%, to $7.90, in premarket trading.
Company director Kevin C. Tang recently acquired about 3 million shares of the company's common stock, according to a filing with the Securities and Exchange Commission.
Write to Michael Dabaie at michael.dabaie@wsj.com
> Dow Jones Newswires
January 14, 2020 07:50 ET (12:50 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM